ZyVersa Therapeutics, Inc. (ZVSA) NASDAQ

0.15

+0.0035(+2.47%)

Updated at September 11 10:20AM

Currency In USD

Valuation

Market Cap1.18M
Enterprise Value-354,289
P/E Ratio-0.84
PEG Ratio-0.02
Price/Sales Ratio44.54
Price/Book Ratio0
Enterprise/Revenue-2,719.71
Enterprise/EBITDA0.03

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-317.94
Operating Margin-160,758.46

Management Effectiveness

Return On Assets-0
Return On Equity-0.01

Income Statement

Revenue0
Revenue/Share0
Gross Profit-6,933
EBITDA-9.14B
Net Income-9.41B
Diluted EPS-8.48

Balance Sheet

Total Cash72.09M
Total Cash/Share1.5
Total Debt0
Total Debt/Equity0
Current Ratio0.04
Book Value Per Share126.71

Price History

52-Week Change-94.42
52-Week High3.37
52-Week Low0.11
Moving Average 50 Days0.26
Moving Average 200 Days0.76

Statistics

Average Volume4.11M
Shares Outstanding8.01M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateApril 26, 2024